Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.
Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...
Ovarian cancer is the sixth most common cancer in women in the UK but the symptoms can be quite subtle, often leaving to a ...
University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...
Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...
THEO-260 is a mechanistically novel oncolytic immunotherapy developed to tackle the stromal rich tumour microenvironment (TME) evident in advanced ovarian cancer and other solid tumours. Suitable ...
It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...
Her latest chapter? Returning to school to earn a master’s degree at the University of Tennessee, Knoxville. In 2016, after an ovarian cancer diagnosis, Sharon was given less than four years to ...
Multi-cancer Early Detection tests can screen for a variety of cancers that don't currently have annual screenings such as ...